In regenerative medicine, addressing the complex challenge of bone tissue regeneration demands innovative strategies. Exosomes, nanoscale vesicles rich in bioactive molecules, have shown great promise in tissue repair. This study focuses on exosomes derived from mineralized osteoblasts (MOBs), which play a pivotal role in bone formation. We investigated the therapeutic potential of exosomes isolated from osteoblasts cultured in osteogenic medium for 21 days, delivered via 3D-printed gyroid scaffolds composed of hydroxyapatite (HA) and tricalcium phosphate (TCP). The exosomes were characterized through nanoparticle tracking analysis to determine size, morphology, and concentration, while proteomics revealed their cargo contents. In vitro, rabbit bone marrow mesenchymal stromal cells (rBMSCs) were cultured as monolayers and within ceramic scaffolds, where MOB-derived exosomes were shown to promote osteogenic differentiation. In vivo, their osteoconductive and bone augmentation capabilities were evaluated in two rabbit calvarial models, while the osteoinductive potential was further tested in a heterotopic mouse model. Neo-bone formation was assessed using µCT and histological analysis. Our findings demonstrated that MOB-derived exosomes upregulated bone-related gene expression and promoted mineralization in rBMSCs, even in the absence of osteogenic medium. Proteomics confirmed the presence of bone-associated proteins in these exosomes. In rabbit models, however, exosomes did not significantly enhance bone formation. In contrast, in the heterotopic mouse model, exosomes functionalized onto ceramic scaffolds exhibited strong osteoinductive activity. This study highlights the potential of MOB-derived exosomes to enhance 3D-printed ceramic scaffolds for bone regeneration, offering a promising avenue for bone healing without the need for additional growth factors or stem cells. STATEMENT OF SIGNIFICANCE: The here presented report of our project not only advances our understanding of the role of exosome-functionalized scaffolds in bone regeneration but also proposes a promising alternative to traditional growth factor- or cell-based approaches. We are confident that this study represents a novel and impactful contribution to the field.
Background/Objectives: Cone-beam computed tomography (CBCT) is widely used in dentomaxillofacial imaging for evaluating bone grafts and implant-related procedures; however, image quality is often compromised by metal-induced artefacts. This study compared CBCT, photon-counting detector CT (PCD-CT), and micro-computed tomography (µCT) for imaging clinically relevant bone graft materials and three-dimensional printed calcium phosphate scaffolds, focusing on biomaterial visualisation and titanium artefact reduction. Methods: Four bovine mandibles were prepared with standardized cylindrical defects containing eight bone substitute materials and 3D-printed calcium phosphate scaffolds, with or without surrounding titanium cages. Specimens were imaged using CBCT and PCD-CT with low-dose and maximum-dose ultra-high-resolution acquisition protocols, and µCT. Two readers independently assessed image interpretability, biomaterial visualisation, and metal artefact severity using a five-point scoring system. Inter-reader agreement was evaluated using weighted Cohen’s kappa. Results: µCT provided the highest spatial resolution and served as the ex vivo reference standard. Under the acquisition and reconstruction protocols evaluated, PCD-CT provided favorable visualization of scaffold architecture and reduced the visual impact of titanium-induced artefacts compared with CBCT. High-energy virtual monoenergetic reconstructions (≥130 keV) further reduced beam-hardening and streak artefacts, although the optimal reconstruction energy may depend on the biomaterial and diagnostic task. Without titanium cages, PCD-CT and µCT achieved higher image interpretability scores than CBCT. With titanium cages, CBCT frequently became non-diagnostic, whereas PCD-CT maintained good visualisation of most biomaterials. Inter-reader agreement ranged from substantial to almost perfect. Conclusions: In this exploratory ex vivo study, the evaluated PCD-CT protocols provided favorable qualitative visualization of several bone graft materials and three-dimensional printed calcium phosphate scaffolds compared with the evaluated CBCT protocol, particularly in the presence of titanium cages. However, the protocols were not dose-matched, and differences in acquisition and reconstruction parameters prevent attributing the observed findings exclusively to detector technology. The study does not establish PCD-CT superiority at equivalent radiation doses or demonstrate clinical performance in longitudinal bone-regeneration monitoring. Further dose-matched studies incorporating objective image-quality measurements and clinical validation are required.